# Equinix Inc: overview

EQIX · Nasdaq · CIK 1101239 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eqix.md) · [Financials](/companies/eqix/financials.md) · [Filings](/companies/eqix/filings.md) · [Insiders](/companies/eqix/insiders.md)

Latest reported revenue: [$2.57bn](/filings/0001101239-26-000180.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 28, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001101239-26-000180).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,261 d](/filings/0001101239-26-000032.md) | [2,225](/filings/0001101239-26-000091.md) | [2,256](/filings/0001101239-26-000147.md) | [2,316](/filings/0001101239-26-000180.md) | [2,420 d](/filings/0001101239-26-000032.md) | [2,444](/filings/0001101239-26-000091.md) | [2,625](/filings/0001101239-26-000147.md) | [2,571](/filings/0001101239-26-000180.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [4.6% d](/filings/0001101239-26-000032.md) | [20.6%](/filings/0001101239-26-000091.md) | [21.9%](/filings/0001101239-26-000147.md) | [20.5%](/filings/0001101239-26-000180.md) | [17.4% d](/filings/0001101239-26-000032.md) | [23.6%](/filings/0001101239-26-000091.md) | [25.3%](/filings/0001101239-26-000147.md) | [23.3%](/filings/0001101239-26-000180.md) |
| Net margin | % | [(0.6%) d](/filings/0001101239-26-000032.md) | [15.4%](/filings/0001101239-26-000091.md) | [16.3%](/filings/0001101239-26-000147.md) | [16.1%](/filings/0001101239-26-000180.md) | [11.0% d](/filings/0001101239-26-000032.md) | [17.0%](/filings/0001101239-26-000091.md) | [18.2%](/filings/0001101239-26-000147.md) | [19.0%](/filings/0001101239-26-000180.md) |
| Diluted EPS | $ per share | not reported | [3.50](/filings/0001101239-26-000091.md) | [3.75](/filings/0001101239-26-000147.md) | [3.81](/filings/0001101239-26-000180.md) | not reported | [4.20](/filings/0001101239-26-000091.md) | [4.83](/filings/0001101239-26-000147.md) | [4.93](/filings/0001101239-26-000180.md) |
| Free cash flow | $m | [(6.0) d](/filings/0001101239-26-000032.md) | [59.0](/filings/0001101239-26-000091.md) | [(45.0) d](/filings/0001101239-26-000147.md) | [(122) d](/filings/0001101239-26-000180.md) | [(292) d](/filings/0001101239-26-000032.md) | [(539)](/filings/0001101239-26-000091.md) | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6,636](/filings/0001628280-24-005350.md) | [7,263](/filings/0001628280-25-005126.md) | [8,188](/filings/0001101239-26-000032.md) | [8,748](/filings/0001101239-26-000032.md) | [9,217](/filings/0001101239-26-000032.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [16.7%](/filings/0001628280-24-005350.md) | [16.5%](/filings/0001628280-25-005126.md) | [17.6%](/filings/0001101239-26-000032.md) | [15.2%](/filings/0001101239-26-000032.md) | [20.0%](/filings/0001101239-26-000032.md) |
| Net margin | % | [7.5%](/filings/0001628280-24-005350.md) | [9.7%](/filings/0001628280-25-005126.md) | [11.8%](/filings/0001101239-26-000032.md) | [9.3%](/filings/0001101239-26-000032.md) | [14.6%](/filings/0001101239-26-000032.md) |
| Diluted EPS | $ per share | [5.53](/filings/0001628280-24-005350.md) | [7.67](/filings/0001628280-25-005126.md) | [10.31](/filings/0001101239-26-000032.md) | [8.50](/filings/0001101239-26-000032.md) | [13.76](/filings/0001101239-26-000032.md) |
| Free cash flow | $m | [(204)](/filings/0001628280-24-005350.md) | [685](/filings/0001628280-25-005126.md) | [436](/filings/0001101239-26-000032.md) | [183](/filings/0001101239-26-000032.md) | [(400)](/filings/0001101239-26-000032.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/eqix/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $11.93bn | 11,444,924 |  | Added +313,356 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $6.72bn | 6,444,422 |  | Added +57,102 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $6.36bn | 6,102,138 |  | Added +98,047 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $6.28bn | 6,026,104 |  | Reduced −52,292 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $3.00bn | 2,874,355 |  | Added +55,781 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $2.64bn | 2,547,307 |  | Added +68,353 |
| [PRINCIPAL FINANCIAL GROUP INC](/funds/1126328.md) | 2026-06-30 | $1.98bn | 1,902,047 |  | Reduced −78,450 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $1.91bn | 1,758,552 |  | Reduced −202,011 |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $1.61bn | 1,546,438 |  | Added +45,879 |
| [COATUE MANAGEMENT LLC](/funds/1135730.md) | 2026-06-30 | $1.33bn | 1,273,517 |  | Added +182,631 |

## Recent filings

[All 2,175 filings](/companies/eqix/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 16:16 ET | [10-Q](/filings/0001101239-26-000180.md) | Quarterly report, period 2026-09-30 | 0001101239-26-000180 |
| 2026-10-28 | 16:12 ET | [8-K](/filings/0001101239-26-000178.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001101239-26-000178 |
| 2026-08-06 | 16:12 ET | [8-K](/filings/0001104659-26-092009.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-092009 |
| 2026-07-29 | 16:20 ET | [8-K](/filings/0001101239-26-000148.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001101239-26-000148 |
| 2026-07-29 | 16:17 ET | [10-Q](/filings/0001101239-26-000147.md) | Quarterly report, period 2026-06-30 | 0001101239-26-000147 |
| 2026-07-29 | 16:13 ET | [8-K](/filings/0001101239-26-000145.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001101239-26-000145 |
| 2026-07-14 | 16:30 ET | [8-K](/filings/0001101239-26-000131.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001101239-26-000131 |
| 2026-05-15 | 16:46 ET | [8-K](/filings/0001101239-26-000109.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001101239-26-000109 |
| 2026-05-11 | 16:28 ET | [8-K](/filings/0001101239-26-000095.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001101239-26-000095 |
| 2026-05-07 | 16:18 ET | [8-K](/filings/0001104659-26-057167.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-057167 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001101239-26-000032.md), filed Feb 11, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/bfec7b1c-7c75-4dcd-aa43-efbc0bbb632c)

## About the filer

- CIK: 1101239
- Tickers: EQIX
- Exchange: Nasdaq
- SIC code: 6798 Real Estate Investment Trusts
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 05:26 ET. No prices; not investment advice.